March 16, 2015 by Chain Drug Review and Chain Drug Review
2015 Analyst Day, Walgreens Boots Alliance
Business, Retail News
DEERFIELD, Ill. — Walgreens Boots Alliance Inc. next month plans to hold its first analyst conference since its formation by the merger of Walgreen Co. and Alliance Boots GmbH. The company said Monday that it will host its 2015 Analyst Day in Manhattan at the Ritz Carlton Hotel Battery Park on April 15 and 16.
March 16, 2015 by Chain Drug Review and Chain Drug Review
Community Pharmacy-Based Point-of-Care Testing certificate program, Continuing Pharmacy Education, NACDS, National Association of Chain Drug Stores, Steve Anderson
Featured Articles, Leading Headlines, Pharmacy, Retail News
ALEXANDRIA, Va. — Next month, the National Association of Chain Drug Stores plans to roll out a certificate program that will train pharmacists to administer point-of-care testing and other health assessments in pharmacies. NACDS said Monday that it will kick off the Community Pharmacy-Based Point-of-Care Testing certificate program in April with multicity tour at pharmacy
March 16, 2015 by Chain Drug Review and Chain Drug Review
Diplomat Pharmacy, public offering, specialty pharmacy
Business, Leading Headlines, Retail News
FLINT, Mich. — Diplomat Pharmacy Inc. has filed a registration statement with the Securities and Exchange Commission for a follow-on public offering of its common stock. The independent specialty pharmacy, the nation’s largest, said late Friday that the offering could raise about $200 million, depending on market conditions. Last October, Diplomat completed an initial public
March 16, 2015 by Chain Drug Review and Chain Drug Review
Comedy for a Cure, CVS Health, CVS/pharmacy, Helena Foulkes, Kari Luther Rosbeck, TS Alliance, Tuberous Sclerosis Alliance
Retail News
SILVER SPRING, Md. — CVS/pharmacy president Helena Foulkes will be honored next month by the Tuberous Sclerosis Alliance (TS Alliance) at the organization’s 14th Annual Comedy for a Cure. The TS Alliance said Friday that Comedy for a Cure will be held April 12 at the Globe Theater in Universal City, Calif. Foulkes also is
March 16, 2015 by Chain Drug Review and Chain Drug Review
Endo International, J. Michael Pearson, pharmaceuticals, Sali, Thomas D'Alonzo, Valeant Pharmaceuticals
Supplier News
LAVAL, Quebec, and RALEIGH, N.C. — Valeant Pharmaceuticals International Inc. has hiked its offer to buy Salix Pharmaceuticals, Ltd. under an amended agreement. The companies said Monday that Valeant boosted its cash offer to acquire all the outstanding common stock of Salix to $173 per share, or a total deal of about $15.8 billion, from $158
March 16, 2015 by Chain Drug Review and Chain Drug Review
Chain Drug Review, Retailer of the Year awards, slideshow
Slideshows
NEW YORK — More than 200 people honored Chain Drug Review’s 2014 Retailer of the Year award winners at the Time-Life Building in Manhattan. Honorees included the CVS/pharmacy retail leadership team for Retailer of the Year, Rite Aid’s Tony Montini for Merchant of the Year, Health Mart’s Steve Courtman for Pharmacy Innovator of the Year
March 16, 2015 by Chain Drug Review and Chain Drug Review
BioRx, Diplomat Pharmacy, infusion services, Phil Hagerman, specialty pharmacy
2015, Issue 03-16-2015, News
FLINT, Mich. — Diplomat Pharmacy, which posted strong financial results for fiscal 2014, is acquiring BioRx LLC, a specialized pharmacy and infusion services company. Based in Cincinnati, BioRx provides treatments for patients with ultra-orphan and rare, chronic diseases. Terms of the agreement call for Diplomat to buy BioRx for $210 million in cash and $105
March 16, 2015 by Chain Drug Review and Chain Drug Review
NACDS, National Association of Chain Drug Stores, Tricare
Uncategorized
WASHINGTON — The National Association of Chain Drug Stores has reiterated its support for allowing members of the armed forces, their dependents and military retirees access and choice in selecting their source of prescription medicines. In a statement delivered during a hearing before the Senate Armed Services subcommittee on personnel, NACDS voiced its opposition to
March 13, 2015 by Chain Drug Review and Chain Drug Review
Nasdaq OMX Group, Nasdaq-100, Walgreens Boots Alliance, WBA
Business, Leading Headlines, News, Retail News
NEW YORK — The Walgreens Boots Alliance Inc. is slated to become part of the Nasdaq-100 Index later this month. The Nasdaq OMX Group Inc. said Friday that Walgreens Boots Alliance, which has the stock symbol WBA, will become a component of the Nasdaq-100 Index (NDX), Nasdaq-100 Equal Weighted Index (NDXE) and NASDAQ-100 Ex-Technology Index
March 13, 2015 by Chain Drug Review and Chain Drug Review
Rite Aid, Stefano Pessina, Walgreens Boots Alliance
CDR Blog
The “Walgreens looking to acquire Rite Aid” rumors have resurfaced following comments by Stefano Pessina, the billionaire investor and acting CEO of Walgreens Boots Alliance. A March 12 article by Reuters quoted Pessina, in remarks at the Retail Week Live conference in London, as saying that of potential deals to be made, “the next big
March 13, 2015 by Chain Drug Review and Chain Drug Review
2015 Annual Legislative Conference, community pharmacy, John Sherrer, National Community Pharmacists Association, NCPA
Retail News
ALEXANDRIA, Va. — The National Community Pharmacists Association plans to hold its 2015 Annual Legislative Conference on May 12 and 13. NCPA said Friday that the conference, to be held at the Hilton Crystal City at Reagan National Airport in Arlington, Va., will draw hundreds of community pharmacy stakeholders to the nation’s capital to advocate
March 13, 2015 by Chain Drug Review and Chain Drug Review
Amy Gordinier-Regan, skin care, Skinfix, SweetSpot LABS
Supplier News
HALIFAX, Nova Scotia — Natural skin care company Skinfix Inc. is merging with SweetSpot LABS, a maker of feminine skin care products. Skinfix said Thursday that the addition of Culver City, Calif.-based SweetSpot will complement its roster of skin healing balms, washes, lotions and creams, which are designed to alleviate a wide range of skin
March 13, 2015 by Chain Drug Review and Chain Drug Review
CHPA, Consumer Healthcare Products Association, Patrick Lockwood-Taylor, Procter & Gamble, Scott Melville
Supplier News
BONITA SPRINGS, Fla. — Procter & Gamble Co. executive Patrick Lockwood-Taylor has been re-elected as chairman of the Consumer Healthcare Products Association (CHPA) board of directors. Lockwood-Taylor, who is vice president of personal health care for North America and digestive wellness design at Procter & Gamble, was named chairman at CHPA’s 2015 Annual Executive Conference,
March 12, 2015 by Chain Drug Review and Chain Drug Review
baby care, CeraVe Baby, National Eczema Association Seal of Acceptance, skin care, Valeant Pharmaceuticals
Supplier News
BRIDGEWATER, N.J. — CeraVe Baby baby care products have been awarded the National Eczema Association Seal of Acceptance. Valeant Pharmaceuticals North America said Thursday that the NEA Seal helps consumers make informed purchasing decisions and recognize skin care products that are suitable for eczema or sensitive-skin. CeraVe Baby products include CeraVe Baby Wash & Shampoo, CeraVe